1
|
Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
|
Bone
|
2005
|
1.80
|
2
|
Improving adherence to and persistence with oral therapy of osteoporosis.
|
Osteoporos Int
|
2015
|
1.46
|
3
|
Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review.
|
Am J Epidemiol
|
2005
|
1.44
|
4
|
Mechanisms of impaired bone strength in type 1 and 2 diabetes.
|
Nutr Metab Cardiovasc Dis
|
2010
|
1.16
|
5
|
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.
|
Vasc Health Risk Manag
|
2010
|
1.15
|
6
|
The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.
|
Calcif Tissue Int
|
2008
|
1.08
|
7
|
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study.
|
Calcif Tissue Int
|
2003
|
1.07
|
8
|
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
|
Bone
|
2006
|
0.99
|
9
|
Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women.
|
Bone
|
2001
|
0.99
|
10
|
[Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)].
|
Reumatismo
|
2011
|
0.97
|
11
|
Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study.
|
Bone
|
2007
|
0.96
|
12
|
Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study.
|
J Clin Densitom
|
2009
|
0.96
|
13
|
Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism.
|
J Neurol Sci
|
1993
|
0.96
|
14
|
Osteoporosis treatment and fracture incidence: the ICARO longitudinal study.
|
Osteoporos Int
|
2008
|
0.93
|
15
|
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study.
|
Osteoporos Int
|
2006
|
0.93
|
16
|
The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.
|
Eur J Intern Med
|
2008
|
0.90
|
17
|
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family.
|
J Med Genet
|
2003
|
0.89
|
18
|
Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.
|
Int J Immunopathol Pharmacol
|
2011
|
0.89
|
19
|
Quantitative ultrasound calcaneous measurements: normative data for the Italian population. the ESOPO study.
|
J Clin Densitom
|
2007
|
0.87
|
20
|
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
|
Bone
|
2006
|
0.87
|
21
|
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis.
|
Osteoporos Int
|
2013
|
0.87
|
22
|
[Guidelines for the diagnosis, prevention and treatment of osteoporosis].
|
Reumatismo
|
2010
|
0.85
|
23
|
Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management.
|
Minerva Cardioangiol
|
2012
|
0.84
|
24
|
Long-term treatment with calcitriol in postmenopausal osteoporosis.
|
Metabolism
|
1990
|
0.84
|
25
|
Methods and clinical applications of total body absorptiometry.
|
J Nucl Med Allied Sci
|
1987
|
0.83
|
26
|
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology.
|
J Steroid Biochem
|
1987
|
0.82
|
27
|
Magnetic resonance imaging in Tietze's syndrome.
|
Clin Exp Rheumatol
|
2008
|
0.82
|
28
|
Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.
|
Int J Clin Pract
|
2007
|
0.82
|
29
|
The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.
|
J Endocrinol Invest
|
1984
|
0.82
|
30
|
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status.
|
Osteoporos Int
|
2004
|
0.81
|
31
|
Choline kinase active site provides features for designing versatile inhibitors.
|
Curr Top Med Chem
|
2014
|
0.81
|
32
|
Secondary osteoporosis.
|
Aging (Milano)
|
1998
|
0.81
|
33
|
Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.
|
Calcif Tissue Int
|
2010
|
0.81
|
34
|
Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis.
|
Calcif Tissue Int
|
1986
|
0.80
|
35
|
Idiopathic avascular necrosis of the scaphoid. A case report.
|
Recenti Prog Med
|
1995
|
0.80
|
36
|
Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3',5'-monophosphate in normal subjects and in pathological conditions.
|
Eur J Clin Invest
|
1980
|
0.80
|
37
|
Leptin and body composition in healthy postmenopausal women.
|
Panminerva Med
|
2001
|
0.80
|
38
|
Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man.
|
J Steroid Biochem
|
1981
|
0.80
|
39
|
Efficacy and safety of a musically modulated electromagnetic field (TAMMEF) in patients affected by knee osteoarthritis.
|
Clin Exp Rheumatol
|
2004
|
0.79
|
40
|
Serum osteocalcin radioimmunoassay in bone diseases.
|
Ric Clin Lab
|
1986
|
0.79
|
41
|
Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
|
Minerva Cardioangiol
|
2005
|
0.79
|
42
|
Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis.
|
J Endocrinol Invest
|
2005
|
0.79
|
43
|
Bone loss in men.
|
Calcif Tissue Int
|
1996
|
0.79
|
44
|
A comparative study of dual-X-ray absorptiometry and quantitative ultrasonography for the evaluating bone status in subjects with Rett syndrome.
|
Calcif Tissue Int
|
2014
|
0.79
|
45
|
The association of body composition and sex hormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women.
|
Calcif Tissue Int
|
2011
|
0.78
|
46
|
Vitamin D metabolites in postmenopausal osteoporosis.
|
Horm Metab Res
|
1984
|
0.78
|
47
|
Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis.
|
Osteoporos Int
|
2006
|
0.78
|
48
|
[Italian guidelines for the diagnosis and treatment of Paget's disease of bone].
|
Reumatismo
|
2007
|
0.78
|
49
|
Accuracy of different reduced versions of a validated food-frequency questionnaire in italian men and women.
|
Calcif Tissue Int
|
2009
|
0.77
|
50
|
Genetics of osteoporosis.
|
Calcif Tissue Int
|
1994
|
0.77
|
51
|
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy.
|
J Endocrinol Invest
|
2009
|
0.77
|
52
|
Relationship between quantitative ultrasound parameters at the calcaneus and health-related quality of life in postmenopausal Italian women: the FEDRO study.
|
Calcif Tissue Int
|
2013
|
0.77
|
53
|
Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
|
Minerva Cardioangiol
|
2007
|
0.77
|
54
|
Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description.
|
Clin Exp Rheumatol
|
2010
|
0.77
|
55
|
Increased phospholipase activity in Helicobacter pylori strains isolated from patients with gastric carcinoma.
|
Dig Liver Dis
|
2005
|
0.77
|
56
|
IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy.
|
Clin Rheumatol
|
2003
|
0.77
|
57
|
Serum proteome of patients with systemic sclerosis: molecular analysis of expression and prevalence of haptoglobin alpha chain isoforms.
|
Int J Immunopathol Pharmacol
|
2010
|
0.77
|
58
|
Macitentan slows down the dermal fibrotic process in systemic sclerosis: in vitro findings.
|
J Biol Regul Homeost Agents
|
2013
|
0.77
|
59
|
The assessment of vertebral fractures in elderly women with recent hip fractures: the BREAK Study.
|
Osteoporos Int
|
2012
|
0.77
|
60
|
Age-related changes in body composition of healthy and osteoporotic women.
|
Maturitas
|
1997
|
0.77
|
61
|
Bone ultrasonography in glucocorticoid-induced osteoporosis.
|
Osteoporos Int
|
2004
|
0.76
|
62
|
The relationship between serum ghrelin and body composition with bone mineral density and QUS parameters in subjects with Rett syndrome.
|
Bone
|
2012
|
0.76
|
63
|
Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
|
Acta Vitaminol Enzymol
|
1984
|
0.75
|
64
|
Expression of RXFP1 in skin of scleroderma patients and control subjects.
|
Scand J Rheumatol
|
2012
|
0.75
|
65
|
Immunolocalisation of ghrelin and obestatin in human testis, seminal vesicles, prostate and spermatozoa.
|
Andrologia
|
2013
|
0.75
|
66
|
Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis.
|
J Biol Regul Homeost Agents
|
2012
|
0.75
|
67
|
Intestinal radiocalcium transport versus urinary calcium excretion in long-term 1,25(OH)2D3 treatment.
|
J Nucl Med Allied Sci
|
1986
|
0.75
|
68
|
[The diagnosis of postmenopausal osteoporosis].
|
Minerva Endocrinol
|
1992
|
0.75
|
69
|
[Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
|
Minerva Med
|
1983
|
0.75
|
70
|
The 24-h urinary cyclic adenosine 3', 5' monophosphate/creatinine ratio: an useful approach to the diagnosis of parathyroid disorders and function.
|
J Endocrinol Invest
|
1982
|
0.75
|
71
|
[Functional constipation and its treatment].
|
Minerva Gastroenterol
|
1974
|
0.75
|
72
|
Glucocorticoids and intestinal absorption of calcium and phosphate.
|
Adv Exp Med Biol
|
1984
|
0.75
|
73
|
[Metabolic changes induced with salmon calcitonin in post-menopausal osteoporosis].
|
Minerva Med
|
1980
|
0.75
|
74
|
Carbocalcitonin treatment in Sudeck's atrophy.
|
Clin Orthop Relat Res
|
1987
|
0.75
|
75
|
A case of acute heart failure associated with Guillain-Barré syndrome.
|
Neurol Sci
|
2006
|
0.75
|
76
|
Pathophysiological aspects of calcium metabolism in spasmophilia.
|
Biomed Pharmacother
|
1987
|
0.75
|
77
|
[Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium].
|
Minerva Med
|
1984
|
0.75
|
78
|
Hypercalcemic effect of nifedipine treatment in man.
|
Boll Soc Ital Biol Sper
|
1977
|
0.75
|
79
|
[Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans].
|
Boll Soc Ital Biol Sper
|
1975
|
0.75
|
80
|
Haptoglobin phenotypes in systemic sclerosis.
|
Clin Exp Rheumatol
|
2009
|
0.75
|
81
|
[Sodium etidronate (EHDP) and osteoporosis].
|
Clin Ter
|
1981
|
0.75
|
82
|
[Synthetic human calcitonin in Paget's disease of bone and osteoporosis (author's transl)].
|
Dtsch Med Wochenschr
|
1981
|
0.75
|
83
|
[Effect of venous infusion of cortisol on the urinary excretion of cyclic AMP in humans].
|
Boll Soc Ital Biol Sper
|
1975
|
0.75
|
84
|
Cyclic AMP urinary excretion and radiocalcium intestinal absorption in hypercalciurias.
|
Boll Soc Ital Biol Sper
|
1977
|
0.75
|
85
|
[An autopsy study of patients who died at the Medical Clinic of the University of Siena from 1986 to 1989].
|
Recenti Prog Med
|
1992
|
0.75
|
86
|
Effects of deflazacort on the renal handling of radiocalcium in man.
|
Adv Exp Med Biol
|
1984
|
0.75
|
87
|
Total body absorptiometry in postmenopausal osteoporosis patients treated with 1 alpha-hydroxylated vitamin D metabolites.
|
Osteoporos Int
|
1993
|
0.75
|
88
|
Occupational asthma due to colophony in non-industrial environments.
|
Med Lav
|
1994
|
0.75
|
89
|
A clinical case of drug hypersensivity syndrome with phenobarbital administration: drug-induced rash with eosinophilia and systemic symptoms or lupus-like syndrome?
|
Clin Exp Rheumatol
|
2007
|
0.75
|
90
|
Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man.
|
Calcif Tissue Res
|
1976
|
0.75
|
91
|
Human calcitonin and malignant osteolysis.
|
Panminerva Med
|
1986
|
0.75
|
92
|
25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man.
|
J Endocrinol Invest
|
1984
|
0.75
|
93
|
Gender-specific associations of appendicular muscle mass with BMD in elderly Italian subjects.
|
Calcif Tissue Int
|
2014
|
0.75
|
94
|
[Correlation between the free thyroxine index and intestinal absorption of radiocalcium in thyroid diseases].
|
Boll Soc Ital Biol Sper
|
1976
|
0.75
|
95
|
[Behavior of blood and urinary magnesium in diabetes mellitus].
|
Boll Soc Ital Biol Sper
|
1978
|
0.75
|
96
|
[Treatment of Sudeck's syndrome with human calcitonin].
|
Dtsch Med Wochenschr
|
1983
|
0.75
|
97
|
[Bone mineral measurement: methodological observations and dosimetric values].
|
Radiol Med
|
1980
|
0.75
|
98
|
Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's disease.
|
Panminerva Med
|
1987
|
0.75
|
99
|
Indirect evidence of calcitonin secretion in man.
|
Clin Sci Mol Med
|
1976
|
0.75
|
100
|
Whole-body retention of 99mTc-MPD in Paget's disease.
|
J Nucl Med Allied Sci
|
1981
|
0.75
|
101
|
[Behavior of blood calcium after oral administration of glucose in subjects with defective intestinal transport of radiocalcium].
|
Boll Soc Ital Biol Sper
|
1976
|
0.75
|
102
|
[Reconstructive surgery of the mitral and tricuspid valves with a Cosgrove-Edwards flexible ring].
|
Ital Heart J Suppl
|
2000
|
0.75
|
103
|
[A case of primary chronic osteomyelitis in a rare site (distal metaphysis of the radius)].
|
Pediatr Med Chir
|
1986
|
0.75
|
104
|
[Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
|
Minerva Med
|
1982
|
0.75
|
105
|
Role of the active vitamin D metabolite and 1 alpha-hydroxylated analogs in the treatment of postmenopausal osteoporosis.
|
J Nutr Sci Vitaminol (Tokyo)
|
1992
|
0.75
|
106
|
Effect of bromocriptine on phosphatemia in acromegaly.
|
Boll Soc Ital Biol Sper
|
1977
|
0.75
|
107
|
The speed of sound correlates with implant insertion torque in rabbit bone: an in vitro experiment.
|
Clin Oral Implants Res
|
2010
|
0.75
|
108
|
[Bone mineralometry in post-menopausal osteoporosis].
|
Minerva Med
|
1983
|
0.75
|
109
|
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
|
Reumatismo
|
2017
|
0.75
|
110
|
Central diabetes insipidus with spontaneous remission. A case report.
|
Recenti Prog Med
|
1998
|
0.75
|
111
|
Perspectives in the treatment and prevention of osteoporosis.
|
Drugs Today (Barc)
|
2009
|
0.75
|
112
|
Current therapeutic strategies in cardiorenal syndrome.
|
Minerva Cardioangiol
|
2012
|
0.75
|
113
|
[Bone mineral measurement in Paget's disease].
|
Boll Soc Ital Biol Sper
|
1978
|
0.75
|
114
|
[Bone mineral content value (single americium 241 energy source) in diabetes mellitus].
|
Radiol Med
|
1980
|
0.75
|
115
|
Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
|
Drug Saf
|
1994
|
0.75
|
116
|
[A case of pseudomembranous colitis in childhood].
|
Pediatr Med Chir
|
1994
|
0.75
|
117
|
[Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
|
Minerva Med
|
1982
|
0.75
|
118
|
[Methods for measuring whole-body adipose tissue: the usefulness of "total body" X-ray densitometry].
|
Minerva Med
|
1992
|
0.75
|
119
|
[Determination of drug costs in general anesthesia].
|
Minerva Anestesiol
|
1992
|
0.75
|